.@davidharsanyi: “As a welfare program, Obamacare might be a success. As a business, though, not so much.” https://t.co/0tE0Uadsk8
— National Review (@NRO) August 20, 2016
RT @chasrmartin: EpiPen Costs Skyrocket, Because Big Government Ruins Everything https://t.co/tJ1y8jcwtD
— WhiteHousePressCorps (@whpresscorps) August 20, 2016
